CO4480039A1 - Vacunas recombinantes de inmunodeficiencia felina producidas en baculovirus y su uso contra la infeccion de virus de inmunodeficiencia felina - Google Patents

Vacunas recombinantes de inmunodeficiencia felina producidas en baculovirus y su uso contra la infeccion de virus de inmunodeficiencia felina

Info

Publication number
CO4480039A1
CO4480039A1 CO96029447A CO96029447A CO4480039A1 CO 4480039 A1 CO4480039 A1 CO 4480039A1 CO 96029447 A CO96029447 A CO 96029447A CO 96029447 A CO96029447 A CO 96029447A CO 4480039 A1 CO4480039 A1 CO 4480039A1
Authority
CO
Colombia
Prior art keywords
feline immunodeficiency
pharmaceutically acceptable
proteins
recombinant
internal gene
Prior art date
Application number
CO96029447A
Other languages
English (en)
Inventor
Terri Wasmoen
Hsien-Jue Chu
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of CO4480039A1 publication Critical patent/CO4480039A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1. UN BACULOVIRUS RECOMBINANTE QUE TIENE POR LO MENOS UN GEN INTERNO QUE COMPRENDE UNA SECUENCIA DE ADN QUE CODIFICA UN MIEMBRO QUE ESTA SELECCIO- NADO DEL GRUPO QUE CONSISTE EN LAS PROTEINAS DE ENVOLTURA DEL VIRUS DE INMUNODEFICIENCIA FELINA (fiv) O LOS FRAGMENTOS INMUNOGENICOS DEL MISMO. 4. UNA VACUNA QUE COMPRENDE: UNA CANTIDAD INMUNOGENICA EFICAZ DE UN POLIPEPTIDO PRODUCIDO POR CELULAS DE INSECTOS INFECTADAS POR BACULOVIRUS RECOMBINANTES QUE TIENEN POR LO MENOS UN GEN INTERNO QUE COMPRENDE UNA SECUENCIA DE ADN QUE CODIFICA UN MIEMBRO QUE ESTA SELECCIONADO DEL GRUPO QUE CONSISTE EN LAS PROTEINAS DE ENVOLTURA DEL VIRUS DE INMUNODEFICIENCIA FELINA (FIV) O LOS FRAGMENTOS INMUNOGENICOS DEL MISMO, UN DILUYENTE O PORTADOR FARMACEUTICAMENTE ACEPTA- BLE Y UN CO-ADYUVANTE FARMACEUTICAMENTE ACEPTABLE. 9. UNA VACUNA QUE COMPRENDE: UNA CANTIDAD INMUNOGENICAMENTE EFICAZ DE UN POLI- PEPTIDO PRODUCIDO POR CELULAS DE INSECTOS INFECTA- DAS CON UN PRIMER BACULOVIRUS RECOMBINANTE QUE TI- ENE POR LO MENOS UN GEN INTERNO QUE COMPRENDE UNA SECUENCIA DE ADN QUE CODIFICA UN MIEMBRO SELECCIO- NADO DEL GRUPO QUE CONSISTE EN LAS PROTEINAS DE ENVOLTURA DE VIRUS DE INMUNODEFICIENICA FELINA (FIV) O FRAGMENTOS INMUNOGENICOS DEL MISMO; UN POLIPEPTIDO PRODUCIDO POR CELULAS DE INSECTOS INFECTADAS CON UN SEGUNDO BACULOVIRUS RECOMBINANTE QUE TIENE POR LO MENOS UN GEN INTERNO QUE COMPREN- DE UNA SECUENCIA DE ADN QUE CODIFICA UN MIEMBRO SELECCIONADO DEL GRUPO QUE CONSISTE EN LAS PROTEI- NAS DE ENVOLTURA DEL VIRUS DE INMUNODEFICIENCIA FELINA (FIV) O FRAGMENTOS INMUNOGENICOS DEL MISMO; UN PORTADOR O DILUYENTE FARMACEUTICAMENTE ACEPTA- BLE Y UN COADYUVANTE FARMACEUTICAMENTE ACEPTABLE. FIGURA 1
CO96029447A 1995-06-07 1996-06-06 Vacunas recombinantes de inmunodeficiencia felina producidas en baculovirus y su uso contra la infeccion de virus de inmunodeficiencia felina CO4480039A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/481,700 US5849303A (en) 1995-06-07 1995-06-07 Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection

Publications (1)

Publication Number Publication Date
CO4480039A1 true CO4480039A1 (es) 1997-07-09

Family

ID=23913018

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96029447A CO4480039A1 (es) 1995-06-07 1996-06-06 Vacunas recombinantes de inmunodeficiencia felina producidas en baculovirus y su uso contra la infeccion de virus de inmunodeficiencia felina

Country Status (6)

Country Link
US (1) US5849303A (es)
AR (1) AR003135A1 (es)
AU (2) AU6037396A (es)
CO (1) CO4480039A1 (es)
WO (2) WO1996040956A1 (es)
ZA (1) ZA964680B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087234B1 (en) 1991-07-09 2006-08-08 Cornell Research Foundation, Inc. Recombinant multivalent viral vaccine
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
EP1668112A4 (en) 2003-06-20 2009-04-29 Protein Sciences Corp SARS IMMUNOGENOUS EXPRESSING VECTORS, SUCH VECTORS OR EXPRESSION PRODUCTS COMPRISING THOSE COMPOSITIONS, PROCESSES AND TESTS FOR THE PREPARATION AND USE THEREOF
WO2006011919A1 (en) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7201903B2 (en) * 2003-09-11 2007-04-10 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7285272B2 (en) * 2003-12-18 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
DE602005027326D1 (de) * 2004-02-19 2011-05-19 Idexx Lab Inc Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
US7335360B2 (en) * 2004-06-30 2008-02-26 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2006011917A1 (en) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US20070135826A1 (en) 2005-12-01 2007-06-14 Steve Zaver Method and apparatus for delivering an implant without bias to a left atrial appendage
JOP20190083A1 (ar) 2008-06-04 2017-06-16 Amgen Inc بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
UY32607A (es) 2009-05-05 2010-12-31 Amgen Inc Mutantes de fgf21 y usos del mismo
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
WO2015077717A1 (en) 2013-11-25 2015-05-28 The Broad Institute Inc. Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
US11725237B2 (en) 2013-12-05 2023-08-15 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
AU2014368898B2 (en) 2013-12-20 2020-06-11 Dana-Farber Cancer Institute, Inc. Combination therapy with neoantigen vaccine
US10993997B2 (en) 2014-12-19 2021-05-04 The Broad Institute, Inc. Methods for profiling the t cell repertoire
WO2016100975A1 (en) 2014-12-19 2016-06-23 Massachsetts Institute Ot Technology Molecular biomarkers for cancer immunotherapy
EP3297660A2 (en) 2015-05-20 2018-03-28 The Broad Institute Inc. Shared neoantigens
TWI750122B (zh) 2015-06-09 2021-12-21 美商博德研究所有限公司 用於贅瘤疫苗之調配物及其製備方法
WO2017184590A1 (en) 2016-04-18 2017-10-26 The Broad Institute Inc. Improved hla epitope prediction
US11549149B2 (en) 2017-01-24 2023-01-10 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
US20210382068A1 (en) 2018-10-02 2021-12-09 Dana-Farber Cancer Institute, Inc. Hla single allele lines
WO2020131586A2 (en) 2018-12-17 2020-06-25 The Broad Institute, Inc. Methods for identifying neoantigens

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US5591572A (en) * 1991-06-14 1997-01-07 St. Vincents Institute Of Medical Research Limited Detection of mammalian immunodeficiency viruses
GB9215232D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
FR2700957B1 (fr) * 1993-01-29 1995-03-03 Seppic Sa Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.
ATE334216T1 (de) * 1994-04-29 2006-08-15 Pharmacia & Upjohn Co Llc Impstoff gegen felines immunodefizienz-virus
FR2721031B1 (fr) * 1994-06-09 1996-07-26 Centre Nat Rech Scient Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic.

Also Published As

Publication number Publication date
WO1996040956A1 (en) 1996-12-19
ZA964680B (en) 1997-12-05
AR003135A1 (es) 1998-07-08
AU6037396A (en) 1996-12-30
AU6093796A (en) 1996-12-30
WO1996040957A1 (en) 1996-12-19
US5849303A (en) 1998-12-15

Similar Documents

Publication Publication Date Title
CO4480039A1 (es) Vacunas recombinantes de inmunodeficiencia felina producidas en baculovirus y su uso contra la infeccion de virus de inmunodeficiencia felina
CO4750842A1 (es) Pox virus recombinantes de mapache y vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina .
PT83434B (pt) Processo de preparacao de virus recombinantes, de peptidos ou proteinas e de vacinas contra o sindroma de imunodeficiencia adquirida
ES2083764T3 (es) Vacuna contra el sindrome respiratorio reproductivo porcino (srrp) y diagnostico.
CA2309003A1 (en) Insect cells or fractions as adjuvant for antigens
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
UY25315A1 (es) Expresión de proteínas en sistemas de expresión en vectores de baculovirus
EA199700215A1 (ru) Защита от вирусных инфекций путем колонизации слизистых оболочек генетически модифицированными бактериями
BR9202024A (pt) Virus de apivox recombinante,cultura de celulas eucariotica infectadas por um virus de avipox,vacina,sequencia de transferencia e plasmideo
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
BR9608716A (pt) Vírus da imunodeficiência felina alterado geneticamente e seu uso como vacina eficaz contra infecção por vírus da imunodeficiência felina
HUP9901005A2 (hu) Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
DK637988D0 (da) Rekombinante polypeptider
ATE294857T1 (de) Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze
ES2118242T3 (es) Vacunas anti virus de la inmunodeficiencia felina (fiv).
ATE208421T1 (de) Stimulierung der immunantwort durch virales protein
AP1561A (en) Use of non-cytolytic retrovirus as vaccines for the treatment of HIV infection.
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
DE69310918D1 (de) Von menschlichen neuroblastomazellen erreichbares virus
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
CN1052506A (zh) 重组日本脑炎分子及其使用方法
TH31607A (th) วัคซีนรีคอมบิแนนท์สำหรับโรคภูมิพร่องในสัตว์ตระกูลแมวที่สร้างในแบคูโลไวรัสและการใช้มันต่อการติดเชื้อไวรัสต่อโรคภูมิพร่องในสัตว์ตระกูลแมว
DE69021879D1 (de) Verfahren zur herstellung von impfstoffen gegen rna-virus.
TH55468A (th) รีคอมบิแนนท์ mva ไวรัสที่แสดงลักษณะแอนติเจนของไวรัสไข้เลือดออกและการใช้งานมันในวัคซีน
TH13647B (th) วัคซีนและวิธีสำหรับการผลิต